Cite
HARVARD Citation
Bsteh, G. et al. (2021). Quantifying the risk of disease reactivation after interferon and glatiramer acetate discontinuation in multiple sclerosis: The VIAADISC score. European journal of neurology. pp. 1609-1616. [Online].